Lv Tao, Zhao Ying, Jiang Xinni, Yuan Hemei, Wang Haibo, Cui Xuelin, Xu Jiashun, Zhao Jingye, Wang Jianlin
College of Biological Resource and Food Engineering, Qujing Normal University, Qujing, Yunnan, China 655011.
Key Laboratory of Yunnan Province Universities of the Diversity and Ecological Adaptive Evolution for Animals and Plants on YunGui Plateau, Qujing Normal University, Qujing, China 655011.
J Cancer. 2021 Oct 17;12(23):7026-7040. doi: 10.7150/jca.62281. eCollection 2021.
Tumorigenesis is closely related to the loss of control of many genes. Urokinase-type plasminogen activator receptor (uPAR), a glycolipid-anchored protein on the cell surface, is controlled by many factors in tumorigenesis and is expressed in many tumor tissues. In this review, we summarize the regulatory effects of the uPAR signaling pathway on processes and factors related to tumor progression, such as tumor cell proliferation, adhesion, metastasis, glycolysis, tumor microenvironment and angiogenesis. Overall, the evidence accumulated to date suggests that uPAR induction by tumor progression may be one of the most important factors affecting therapeutic efficacy. An improved understanding of the interactions between uPAR and its coreceptors in cancer will provide critical biomolecular information that may help to better predict the disease course and response to therapy.
肿瘤发生与许多基因调控失控密切相关。尿激酶型纤溶酶原激活物受体(uPAR)是一种细胞表面糖脂锚定蛋白,在肿瘤发生过程中受多种因素调控,且在许多肿瘤组织中表达。在本综述中,我们总结了uPAR信号通路对肿瘤进展相关过程和因素的调控作用,如肿瘤细胞增殖、黏附、转移、糖酵解、肿瘤微环境和血管生成。总体而言,迄今为止积累的证据表明,肿瘤进展诱导uPAR可能是影响治疗效果的最重要因素之一。更好地理解癌症中uPAR与其共受体之间的相互作用,将提供关键的生物分子信息,有助于更好地预测疾病进程和对治疗的反应。